CMIIU
Cm Life Sciences II Inc
A special purpose acquisition company, or SPAC — a "blank check" firm formed to raise money through an IPO and then merge with an existing private company to take it public. Backed by investment firms Casdin Capital and Corvex Management, CM Life Sciences II focused on the life sciences sector, including tools, synthetic biology, and diagnostics. In 2021 it merged with the proteomics company SomaLogic, which adopted the combined name and began trading on the Nasdaq.
UNITUnderlying: CMIIUCUSIP: 125842203HealthcareUS1 holder
Unit (1 Class A Share + 1/5 Warrant) — Acquired by SomaLogic Sept 2021
Recent Activity
2021Q4
1 sell
-2.74M shares
-2.74M shares
2021Q3
1 buy1 sell
+2.55M shares(+1324.0%)
+2.55M shares(+1324.0%)
-2.85M shares
ARK InvestEXIT
-2.85M shares
2021Q2
2 buys1 sell
+192.4K shares
+192.4K shares
+2.85M shares
ARK InvestNEW
+2.85M shares
-100.0K shares
Maverick CapitalEXIT
-100.0K shares
2021Q1
1 buy
+100.0K shares
+100.0K shares